
An experimental drug shielded celiac patients during a gluten challenge.
A 32-person study found less injury and fewer symptoms—but it is still early.
Every serving. No expiration date. Page 3 of 7.

A 32-person study found less injury and fewer symptoms—but it is still early.

A monitor improved when patients could explain what its sensors got wrong.

In the OPTIMA extension, adults who stayed on Pasatru had no new lesions detected between weeks 56 and 84; the placebo group had nine.

A new WHO review says transmission now remains only in the remote cross-border Yanomami Focus Area shared by Brazil and Venezuela.

Nine hundred thirty-nine completed rehabilitations turned underused historic buildings back into homes, businesses, workplaces and community spaces while supporting an estimated 163,000 jobs.

Battery installations jumped 52% from the previous half-year while households added a record 1,894 MW of rooftop solar.

The 2026 count was the highest in Georgia’s statewide record. The long-run nesting trend has risen about 4% a year since the early 1990s.

More than 7.86 million people have been screened. Diagnosis reached 92.4%, treatment 92.7%, and treatment in key high-risk groups 95%.

The national average rose above one tonne per hectare in 2025–26; some farmer-field-school groups reached 1.4 to 2 tonnes while cutting pest treatments.

Demand broke records. The emergency alerts did not arrive. Since 2023, Texas added 19.5 GW of solar and 16 GW of battery storage.

A preclinical formulation held onto its biological activity for more than two months at 37°C—and matched fresh material in mouse immune-response tests.

Three mother-and-young pairs and two adolescent males passed health checks before being released into a protected 23,000-hectare forest.

The lower dose met the trial’s main goal over 52 weeks. The higher dose did not, and the detailed results are not yet published.

A six-month pilot will replace gasoline generators with batteries, cutting fumes and noise while gathering real-world data for thousands of street vendors.

The first 33-megawatt block is earning revenue under a power-purchase agreement. Two more blocks are due to complete the 100-megawatt first phase.

WHO/Europe calls the result an early signal: the evaluation covers five months and independent peer review is pending.

SB 868 treats certified portable solar more like a household appliance: utilities may require a simple online registration, but not prior approval.

The fund starts with $9 million from Walmart Foundation and $9 million in aligned investment from McDonald’s USA and suppliers.

The national estimate is up from 148–189 in 2022. A monitored tigress has raised three litters—nine cubs—and one daughter is already breeding.

The advocacy-group analysis also found burned areas from 2016–2026 were concentrated in acid grassland, heather, bog and other simplified landscapes rather than restored habitat.

The 3–2 ruling invalidated an expansion approval after the planning commission focused on only 2% of projected emissions and did not consider conditions for the other 98%.

In a 10-person safety trial, an experimental optogenetic treatment produced clinically meaningful light-sensitivity gains in six participants. It did not restore normal sight.

Two captive-bred males are now walking free in the Thar Desert. The release is a test, not a declaration of recovery.

More than 500 pocket mice have been released over 20 years. North San Mateo is now the third reintroduced population.